Number of shares and votes in Oncopeptides

LHFI

Stockholm — 28 February, 2025 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that the number of shares and votes in Oncopeptides has changed as a result of the company’s issue of 10,572,577 new class C shares. The shares are issued by virtue of the Annual General Meetings’ resolution on 31 May 2024 on authorisation for the Board of Directors to resolve on issue of class C shares to enable delivery of shares to participants under the incentive programs Co-worker LTIP 2022, Co-worker LTIP 2024 and Board SHP 2024 as well as other outstanding shareholder programs for members of the Board of Directors.

Before the share issue, the total number of shares in Oncopeptides amounted to 215,186,246 and the total number of votes in Oncopeptides amounted to 211,656,137.3. As a result of the share issue, the number of shares in Oncopeptides has increased by 10,572,577 class C shares, corresponding to 1,057,257.7 votes. As of today, the total number of shares in Oncopeptides amounts to 225,758,823 shares, of which 211,263,903 are ordinary shares and 14,494,920 are class C shares. The number of votes in Oncopeptides as of today amounts to 212,713,395. The share capital has increased by SEK 1,174,730.825486 from SEK 23,909,583.859895 to SEK 25,084,314.685381.

Datum 2025-02-28, kl 17:50
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!